A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB

Clinical trial NCT02333799 · COMPLETED

Trial details

NCT number: NCT02333799
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2015-03-01
Primary completion: 2019-01-14
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.